Legend Biotech Corporation

1. 01

   Behind SPY over 1 year

   1 month: +21.6% (SPY −1.6%). 3 months: +19.5% (SPY −0.4%). 1 year: −29.0% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: LEGN, SPY · as of 4 Nov 2026

2. 02

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $22.77 was 16.3% above its 50-day average ($19.58) and 2.9% above its 200-day average ($22.12). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 31 Aug 2026, 46 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

3. 03

   6.7 days to cover short interest

   13.9M shares were sold short at the 15 Oct 2026 settlement, 7.2% of the 193.8M shares outstanding; covering them would take 6.7 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

4. 04

   31% of the way up its 52-week range

   Closed at $22.77 on 4 Nov 2026: 39.3% below the 52-week high of $37.50 (3 Jun 2026) and 40.2% above the low of $16.24 (4 Feb 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Volume 1.6× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 3.2M shares was 1.6× the average of the 30 sessions before it (2.0M), as the price rose 6.0%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

At the 4 Nov 2026 close